Intensive Update in Neurology: Online Module

Course Description | Accreditation| General Information | Registration Fees | Online CME Modules

As of July 7, 2016, these online courses are no longer eligible for CME credit. We apologize for any inconvenience.

Please note: These modules will not currently work on Internet Explorer 10 or 11.  If you are using Internet Explorer 10 or 11, please use a different browser to complete these modules.  We apologize for the inconvenience and are working quickly to get the problem resolved.   Please contact with any questions.

To earn CME Credit, you must review the information below, click on the catalog of online modules, watch a presentation in its entirety, complete a short evaluation and quiz and register/pay (non-Swedish).

Course Description

The goal of the Intensive Update in Neurology enduring program is to share practical information on the management of patients with a variety of neurological diseases. Viewers will be equipped to provide high-quality care to their patients with dementia, stroke, epilepsy, multiple sclerosis, Parkinson’s disease, movement disorders, migraine, episodic vertigo, intracranial hypertension and hypotension, brain tumors, hearing loss, neuro-infectious diseases, spine pain, and depression, neuro ophthalmic emergencies, posttraumatic headaches, neurological conditions associated with HIV, pain associated with neurological conditions, Tourette's syndrome, and sleep disorders. An update on trial data for treating amyotrophic lateral sclerosis (ALS) will give insight for working with patients who have ALS. These neurologic conditions may be encountered by primary-care physicians and allied health providers at any time, and updates in diagnostic criteria and treatment options are vital to the care of their patients. These topics may be encountered by primary-care physicians and allied health providers at any time, and updates in diagnostic criteria and treatment options are vital to the care of their patients. By allowing access to this material online, physicians and allied health professionals who may not have been able to attend the live sessions will also be provided with this up-to-date information on a regular basis.

Target Audience

The recorded lectures from the Intensive Update in Neurology symposium are intended for general neurologists, neurology residents and fellows, primary-care and family medicine physicians, advanced practice clinicians, psychiatrists, psychologists, allied health providers and neurosurgeons. This activity will be publically accessible to clinicans worldwide.

Learning Objectives

At the conclusion of this course, the participant will provide better patient care through an increased ability to:

20 Years, 10 Therapies: Benefits and Risks of Multiple Sclerosis (MS) Treatments
Pavle Repovic, M.D., Ph.D.

  • Discuss the efficacy of approved treatments for Multiple Sclerosis (MS), as established in their pivotal trials, list the known risks and side effects of each treatment class and provide tools for individual risk/benefit assessment, including the risk of inadequate disease control

Advanced Technologies for the Treatment of Hearing Loss
Douglas D. Backous, M.D.

  • Outline the role of electrophysiology in hearing loss assessment; list the indications for cochlear implants and brainstem implants.

Approach to Pituitary Patients for the Neurologist
Kevin C. J. Yuen, M.D., MBChB, FRCP

  • Describe how to approach pituitary function, discuss treatment of pituitary hormone dysfunction and review common presentations of pituitary patuents

Diagnosis of Alzheimer's Disease
Vivek Manchanda, M.D.

  • Discuss amyloid PET scan and DAT scan and their sensitivity and specific uses

Epileptic Syndromes in Infancy and Childhood
Ednea A. Simon, M.D.

  • Recognize different epileptic syndromes in infancy and childhood, review EEG findings and seizure semiology in epileptic syndromes in infancy and childhood and outline treatment and prognosis in epileptic syndromes in infancy and childhood

Episodic Vertigo
Eugene F. May, M.D.

  • Generate a differential diagnosis of episodic vertigo, differentiate peripheral vs. central etiology of vertigo and review treatment options for various types of episodic vertigo

Genetics of Parkinson's
Cyrus Zabetian, M.D., MS

  • Review the continuum of genetic risk for Parkinson's disease, discuss the appropriate use of clinical genetic testing and describe how genetic data might be used to inform future clinical trials

Intracranial Hypotension
Charles S. Cobbs, M.D.

  • Recognize intracranial hypotension, describe the diagnosis and identification of causes of intracranial hypotension and manage intracranial hypotension

Major Depressive Disorder, Agitation
Lina Fine, M.D., MPhil

  • Explain  the correct use of psychotropic medications in patients with neurological conditions, explain how to switch antidepressant and use adjunctive therapies in the specific neurological population; and manage agitations in outpatient setting pharmacologically and through behavioral recommendations to the patients and caretakers

Migraine Treatment: What's Around the Corner?
Anna Wong, M.D.

  • Outline current and upcoming migraine treatments

Neuro-infectious Diseases Update 2014
Emily L. Ho, M.D., Ph.D.

  • Describe the clinical presentation , appropriate diagnostic studies and apply the appropriate treatment for Lyme disease; and discuss recent updates and advances in the field of neuro-infectious disease

Neuro-Oncology Update
John W. Henson, M.D., FAAN

  • Review therapeutic management for patients with glioblastoma and discuss clinical trial therapeutics on the horizon for glioblastoma

Neurotoxin Applications for Treatment of Neurogenic Bladder Patients
Mia A. Swartz, M.D., MSE

  • Review history of neurotoxins and their mechanism of action, explain initial evaluation of neurogenic bladder patient and how to identify neurotoxin treatment candidates and describe three neurotoxin applications for treatment of neurogenic bladder issues and outcomes

New Molecular Approaches to Diagnosing and Treating Dementia
Bruce L. Miller, M.D.

  • Explain how degeneration of specific neuroanatomical systems gives rise to specific behavioral dysfunctions, describe the neuropathology and genetics of neurodegenerative diseases leading to dementia and identify current and potential directions for the development of treatments

Selected Women's Issues in Epilepsy
Lisa M. Caylor, M.D.

  • Outline the known major teratogenic risks of anticonvulsants, manage anticonvulsants during pregnancy and in the postpartum period and review obstetric risks in women with epilepsy

Spinal Pain
Gordon A. Irving, M.D.

  • Review some of the pathophysiology that may perpetuate spinal pain, develop a logical approach to treatment of spinal pain  and decide when certain investigations and procedures are indicated and when they are not

The IIHTT: a Multicenter, Double-Blind, Randomized Clinical Trial Comparing Acetazolamide and Placebo on Visual Outcome
Steven R. Hamilton, M.D.

  • Describe the first year results of the Idiopathic Intracranial Hypertension Treatment Trial, review current grading system of papilledema and outline the medical and surgical treatment options for intracranial hypertension

The Spectrum of Immune-Mediated Neuropathis: Presentation, Pathogenesis and Treatment
Michael D. Weiss, M.D., FAAN, FANA

  • Recognize classic and atypical presentations of inflammatory neuropathies, identify autoantibodies associated with these disorders that aide in their diagnosis and management and formulate appropriate algorithms for treating these forms of peripheral neuropathy

Twists and Twitchings: Common Hyperkinetic Movement Disorders
Susie I. Ro, M.D.

  • Describe phenomenology, diagnosis and management of common hyperkinetic movement disorders and describe several video case studies

Update in Rehabilitation Techniques
Angeli Mayadev, M.D.

  • Describe new technologies in rehabilitation medicine and discuss robotic devices for rehabilitation

Update on Stroke
Aaron N. Stayman, M.D.

  • Describe current evidence-based approaches to acute stroke management, review new evidence in secondary stroke prevention and discuss what's new in stroke rehabilitation
Keynote: Intraspinal Stem Cell Transplantation in ALS: Clinical Trials Update
Eva L. Feldman, M.D., Ph.D.
  • Review the different types of stem cells (embroyonic, adult, mesenchymal, iPS) used in ALS preclinical trials
  • Explain the steps required to translate a preclinical cellular therapeutic into a Phase 1 trial 
  • Discuss the current results of the completed FDA approved trials
Concussion and Management of Posttraumatic Headache
Sylvia Lucas, M.D., Ph.D.
  • Describe the epidemiology of concussion and post-traumatic sequelae
  • Discuss the prevalence and clinical presentation of post-traumatic headache 
  • Describe the approach to the management of post-traumatic headache
Dementia: Recent Advances in Criteria, Pathogenesis and Imaging
Henry Querforth, M.D., Ph.D.
  • Explain the new criteria for Alzheimer’s Disease
  • Discuss mechanisms of disease spread and network failure 
  • Review new imaging resources
Update on Surgical Intervention for Movement Disorders
Susie I. Ro, M.D. 
  • Compare Deep Brain Stimulation (DBS) vs. "non-invasive thalamotomy" techniques (MRfFUS and GKS) for Tremor
  • Recognize which patients with Parkinson's Disease would benefit from surgery 
  • Discuss the timing and choice of surgery; and review several case studies of surgery for tremor or parkinsonism using an algorithmic approach
Atypical Parkinsonism: When it’s Not Idiopathic PD
Rosalind Chuang, M.D.
  • Describe different forms of parkinsonism 
  • Discuss diagnostic criteria of different forms of atypical parkinsonism
Neuro-Ophthalmic Emergencies
Steven R. Hamilton, M.D. 
  • Recognize urgent neuro-ophthalmic diagnoses that mandate urgent evaluation
  • Review common presentations of true and false ophthalmic emergencies 
  • Discuss appropriate triage for true neuro-ophthalmic emerging conditions
Neuro Ophthalmology: Evaluating Pupillary Abnormalities
Eugene F. May, M.D.  
  • Perform clinical assessment of anisocorie
  • Explain the pharmacology of pupillary function 
  • Describe neurologic emergencies that present with anisocorie
Stroke Update: “All You Guys Do is Put People on Aspirin, Right?”
Aaron N. Stayman, M.D.
  • Review the results and implications of trials for thromectomy in acute stroke published in 2015
  • Discuss secondary prevention including optimal treatment for prevention of stroke inarterial dissection 
  • Discuss rehab: what works and what doesn't work
Management of HIV-infected Patients for the Neurologist
Emily Ho, M.D.
  • Review how to diagnose neurological issues in HIV-infected patients 
  • Discuss how to manage HIV-infected patients with neurological symptoms and disease
The New Era of Neurohospitalists
Sheila D. Smith, M.D.
  • Describe what a neurohospitalist is
  • Outline the advantages and disadvantages to this care delivery model 
  • Discuss how we can improve the transition from hospital care to clinic
Multimodal Evidence-based Pain Management
Jennifer M. Lee, M.D.
  • Review the evidence in support of multimodal approach to chronic pain management 
  • Describe the operation of a multimodal pain management system
Charles S. Cobbs, M.D.
  • Describe the basic molecular biology and growth patterns of meningiomas
  • Outline treatment strategies for various types of meningiomas 
  • List and describe treatment strategies for malignant meningioma
Personalized Treatment in Neuro-Oncology
Tara L. Benkers, M.D.
  • Explain the concept of inter-tumeral and intra-tumoral heterogeneity that exists in cancer and primary brain tumors
  • Explain that a single bullet is an unrealistic approach for achieving durable treatment responses 
  • Explain that personalized therapy is needed to successfully target differences from patient to patient as well as the cloncal diversity with each patient's tumor
Brain Tumors and Epilepsy
Michael J. Doherty, M.D., FAAN
  • Discuss anti-epileptic medication choices for brain tumor patients
  • Describe pathologies of brain tumors and their treatments, that might make seizures more likely
  • Review individulalized therapies in settings of tumor progression, anxiety and/or depression
Multiple Sclerosis: New Therapies
James D. Bowen, M.D.
  • Review recently approved medications for multiple sclerosis (MS) treatment 
  • Review the side effects of various treatments
Progressive Multiple Sclerosis: What is to Be Done?
Pavle Repovic, M.D., Ph.D.
  • Recognize the symptoms of progressive MS and their evolution over time
  • Review the results of clinical trials for progressive MS 
  • Develop a practical approach to treatment, education and support for patients with progressive MS
Tourette’s Syndrome
Anthony A. Bouldin, M.D.
  • Discuss the new diagnostic critera for Tourette syndrome and review treatment options for Tourette syndrome
Ketogenic Diet and Modified Atkins Diet for Treatment of Epilepsy
Ednea A. Simon, M.D. 
  • Describe the ketogenic diet and the modified Atkins diet
  • Evaluate the ketogenic diet and modified Atkins diet efficacy 
  • Review the side effects of the ketogenic diet and modified Atkins diet
Sleep in Neurology
Lina Fine, M.D., MPhil
  • Review the pathophysiology of sleep disorders in neurological conditions
  • Discuss the latest developments in treatment modalities 
  • Describe the impact of sleep on the course of neurological conditions
Immunosuppressive Therapy in Neurology – the Good, the Bad and the Ugly
Gloria von Geldern, M.D.
  • Explain the use of immunosuppressive therapy in neurology with a focus on neuroimmunology
  • Assess the need for and scope of pre-treatment and on-treatment monitoring and risk management of immunosuppressive therapy
  • Review neurological complications of immunosuppresive therapy, in particular Progressive Multifocal Leukoencephalopathy (PML)

Planning Committee Disclosures

Eric P. Gierke, M.D., Chair
   Disclosure: None
Lisa M. Caylor, M.D.
   Disclosure: None
Michael J. Doherty, M.D.
   Disclosure: None
Laura E. Jacob, MEd, Education Program Administrator
   Disclosure: None
Eugene F. May, M.D.
   Disclosure: None
Jennifer L. More, R.N., Nursing Education
   Disclosure: None
Pavle Repovic, M.D., Ph.D.
   Disclosure: Consultant for Biogen, Novartis and Teva; Speaker for Acorda, Biogen, Novartis, Pfizer/EMD Serono and Teva; Grant/Research Support for Novartis
Elaina Robinson, R.N., Nursing Education
   Disclosure: None
Ednea A. Simon, M.D.
   Disclosure: None
Jennifer L. Witt, M.D.
   Disclosure: Speaker for Teva
Anna Wong, M.D.
   Disclosure: None

Speaker Disclosures

Each speaker's disclosures are listed in the catalog of online modules. Swedish CME maintains full control of the content of every course we provide. It is our policy to identify and resolve all conflicts of interest. Each speaker is required to give a balanced, evidence-based presentation that is free of commercial bias.

Commercial Support

No commercial support was used in the development of this CME learning activity.


Accreditation with Commendation
Swedish Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™

Swedish Medical Center designates this enduring activity for a maximum of 14 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Each session is designated for 0.5 - 1.0 AMA PRA Category 1 Credit™.

Each hour is designated for 1 AMA PRA Category 1 Credit™. For Physicians: The number of hours participated equals the number of AMA PRA Category 1 Credits™ claimed and awarded, with one hour of participation equaling one AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity, and should claim credit in 15 minute or 0.25 credit increments.


General Information

System Requirements
Before viewing the video, please test your system.

To print your Certificate of Completion at the end, you will need Adobe Acrobat Reader. Follow the instructions on that page to download and install the software.
This enduring material requires the participant to watch recorded lectures and score 100% on an online quiz related to the content.

Estimated Time to Complete
Allow 15-60 minutes to watch each video and complete the quiz and evaluation.

Important Dates
Release Date: October 1, 2014; Additions: October 1, 2015
End Date: December 31, 2017

Contact Information
Swedish CME: 206-386-2755 or email

Privacy & Confidentiality
The department of Continuing Medical Education at Swedish Medical Center is committed to protecting the privacy of those who utilize its Web site. The CME department will not release individual information about use of its site, including visitor e-mail addresses, to any third party. We will not transfer, sell or rent visitor e-mail addresses to any third party. The CME department may report general information about the activity to third parties. We will report only aggregate statistics, for instance, total number of page views, overall duration of visits, or similar aggregate data. The CME Department at Swedish Medical Center has taken reasonable steps to keep all information secure against unauthorized access and use. We will review our privacy policy regularly. Please direct any questions about this privacy statement to Swedish CME.

This learning activity is the property of Swedish Medical Center.


Registration Fees

Swedish Provider

No charge


$35 per lecture

Allied Health

$18 per lecture

Medical Student, Resident or Fellow

No Charge

Online CME Modules

Click below to view a complete list of online modules available for CME credit. At the end of each video, you will recieve instructions on how to claim CME credit.
 View Catalog of Online Modules